Between the NTP scuffle and this new one with Minerva, RIM might be able to skip all the paperwork simply by filing their patents first, according to some new changes in U.S. legal system. If all goes according to plan, patent litigations could be resolved solely based on who filed the patent first, rather than who was the first to invent the technology in question. The movement’s getting mixed reviews from industry. Big companies like RIM are in a good spot, because each devices has so many associated patents, that should even one be objected to, the entire device is mired in legal trouble. Biotech companies, which rely conversely on single patents, could see their funding diminish since the patent’s worth would only be established by review after the application.